CONCEPT OF LOADING AND
MAINTENANCE DOSE
6/5/2022 1
CONTENT
 INTRODUCTION
 DEFINITION
 CONCEPT
 FACTORS
 REFERENCE
6/5/2022 2
INTRODUCTION
 Most drugs for chronic condition are
prescribed in a dosage regimen is
based on the administration of a fixed
constant dose(D) at fixed regular
dosing intervals(T) for long period of
time.
 The D & T recommended by the
manufacturer is based on the effective
therapeutic concentration of drug in
the plasma needed to treat the chronic
condition.
6/5/2022 3
 The T is based on elimination rate
constant of the drug.
 The steady-state concentration of drug
in plasma during multiple dosing is
given by following equation:
6/5/2022 4
 The concentration of drug in plasma at
steady-state depends on the following
3 factors:
a) C0, concentration of drug in plasma.
b) Ke, elimination rate constant.
c) T, the dosing interval.
6/5/2022 5
DEFINITION & CONCEPT
 Loading dose: A dose of medication,
often larger than subsequent doses,
administered for the purpose of
establishing a therapeutic level of the
medication.
 Primary purpose of using loading dose in
therapeutic treatment is to attain steady-
state concentration of the drug as quickly
as possible, usually right from the start of
the dosage regimen for the treatment.
6/5/2022 6
 This approach may also reduce the
time of onset of drug action, i.e; the
time its takes to achieve the minimum
effective concentration.
 The purpose of administering the
loading dose is to reduce the time
needed for the drug to accumulate to
the steady-state level in the plasma.
 The size of loading dose will depend
on the T of the maintenance dose.
6/5/2022 7
INTRAVENOUS
ADMINISTRATION
 A drug when administered
intravenously as a single rapid bolus
dose, confers the characteristics of
one-compartment model on the body.
 The main purpose of loading dose(D*)
is to provide a steady-state
concentration in plasma during
multiple dosing.
6/5/2022 8
Loading dose based on Cmax
ss
 The max concentration of drug in the
plasma at steady-state, Cmax ss is given
by equation
C0 is plasma concentration
immediately after administration of a
single dose.
e-p is persistence factor where P=(Ke)
(T) 6/5/2022 9
 If the drug follows linear
pharmacokinetics then C0 obtained
after the administration of single i.v
rapid bolus dose is directly
proportional to size of dose
D(maintenance dose).
 The max concentration at steady-state
is
6/5/2022 10
 Concentration of drug in plasma
immediately after administration of the
first dose is given by
 Vd= apparent volume of distribution
 therefore
6/5/2022 11
 The max conc after the first dose is
 Since Cmax 1 = Cmaxss, the conc *C0 of
drug in plasma immediately after (D*) is
given by
*C0 = Cmaxss
 Substuting *C0 and Cmaxss gives
6/5/2022 12
 The size of loading dose depends on
the following factors-
a) Maintenance dose ,D
b) Elimination rate constant , Ke
c) Dosing interval ,T.
6/5/2022 13
Loading dose based on Cmin ss
 The minimum concentration of drug in
plasma at steady-state is given by
equation
 If drug follows linear p’kinetics then C0
is directly proportional to size of D
 The min concentration of drug in
plasma at steady-state is
6/5/2022 14
 When a single bolus dose of the drug
is administered intravenously
 Therefore
6/5/2022 15
 The min conc of drug in plasma after
administration of first dose
 For D* Cmin 1 = (*C0 ) (e-p ),which
should be equal to Cmin ss
 Combining eq
6/5/2022 16
 Common terms canceled
6/5/2022 17
Factors affecting size of dose
 If all doses and all T are kept
constant, then the size of D depends
on size of D*, T & Ke
Effect of dosing interval:
 If the size of D is kept constant &
biological halflife of the drug dose not
change during the course of therapy,
the size of D* depends entirely upon
the T of a given drug.
6/5/2022 18
EXTRAVASCULAR
ADMINISTRATION
 For the determination of D* during e.v,
administration, the simplest case is a
drug which, when administered,
confers upon the body the
characteristics of one-compartment
model, & does not exhibit lag-time.
 The size of D* needed to attain
steady-sate conc of drug in plasma
depends on:
6/5/2022 19
a. Maximum concentration of drug in
plasma at steady state. OR
b. Minimum concentration of drug in
plasma at steady state.
LOADING DOSE BASED ON Cmaxss
 The maximum concn of drug in
plasma at steady-state is given by
6/5/2022 20
 Where B is the back extrapolated y-
intercept of the elimination phase after
administration of a single dose.
 R=(Ke) (tmax)
6/5/2022 21
Loading dose based on Cmin ss
 The minimum conc of drug in plasma
following e.v adminstration of n dose
 If the drug follows linear
pharmacokinetics then B
 F=fraction of dose absorbed
 G= (Ka)( T)
6/5/2022 22
 By setting n=1 in above eq in Cmin1
 Canceling common terms
 When n becomes large, the two
exponential terms e-np e-nG approach 0
6/5/2022 23
 Since the y-intercept,Cmin1 is directly
proportional to D
 If D is administered at the first dose
6/5/2022 24
 When Cmin1=Cminss
 Substituting the values
 Bringing RHS of eq to common
denominator
 Upon simplification
6/5/2022 25
 Dividing both side by (e-p – e-G)
 Cancelling common term
6/5/2022 26
Maintenance Dose
 After the loading dose is given the
another dose is given to maintain the
steady- state drug conc. / plateau.
Such dose is known as maintenance
dose.
 i.e. maintain the response of drug by
replacing drug lost during dosing
interval
6/5/2022 27
 Maintenance dose = loading dose . ( 1- e k‫ז‬)
 Loading dose =
 The ratio of loading dose to maintenance
dose (X0l/X0) is called as dose ratio
 When ‫ז‬ = t1/2 the dose ratio =2.0
 When ‫ז‬ > t1/2 the dose ratio < 2.0
 when ‫ז‬ < t1/2 the dose ratio >2.0
6/5/2022 28
6/5/2022 29
Maintenance of drug within the
therapeutic range
The ease or difficulty in maintaining drug
concentration within the therapeutic
window depends on-
 The Therapeutic index of drug
 The Half- life of drug
 Convenience of dosing
6/5/2022 30
REFERENCE
 Madan PL;Biopharmaceutics and
pharmacokinetics. Jaypee.2010(1);365-80.
 Brahmankar DM, Sunil Jaiswal B;
Biopharmaceutics and Pharmacokinetics-
A Treatise. Vallabh publication. 2014(3);
374-76.
 C V S Subrahmanyam. Textbook of
Biopharmaceutics & pharmacokinetics.1st
edition 2010;456-61.
6/5/2022 31
6/5/2022 32

CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptx

  • 1.
    CONCEPT OF LOADINGAND MAINTENANCE DOSE 6/5/2022 1
  • 2.
    CONTENT  INTRODUCTION  DEFINITION CONCEPT  FACTORS  REFERENCE 6/5/2022 2
  • 3.
    INTRODUCTION  Most drugsfor chronic condition are prescribed in a dosage regimen is based on the administration of a fixed constant dose(D) at fixed regular dosing intervals(T) for long period of time.  The D & T recommended by the manufacturer is based on the effective therapeutic concentration of drug in the plasma needed to treat the chronic condition. 6/5/2022 3
  • 4.
     The Tis based on elimination rate constant of the drug.  The steady-state concentration of drug in plasma during multiple dosing is given by following equation: 6/5/2022 4
  • 5.
     The concentrationof drug in plasma at steady-state depends on the following 3 factors: a) C0, concentration of drug in plasma. b) Ke, elimination rate constant. c) T, the dosing interval. 6/5/2022 5
  • 6.
    DEFINITION & CONCEPT Loading dose: A dose of medication, often larger than subsequent doses, administered for the purpose of establishing a therapeutic level of the medication.  Primary purpose of using loading dose in therapeutic treatment is to attain steady- state concentration of the drug as quickly as possible, usually right from the start of the dosage regimen for the treatment. 6/5/2022 6
  • 7.
     This approachmay also reduce the time of onset of drug action, i.e; the time its takes to achieve the minimum effective concentration.  The purpose of administering the loading dose is to reduce the time needed for the drug to accumulate to the steady-state level in the plasma.  The size of loading dose will depend on the T of the maintenance dose. 6/5/2022 7
  • 8.
    INTRAVENOUS ADMINISTRATION  A drugwhen administered intravenously as a single rapid bolus dose, confers the characteristics of one-compartment model on the body.  The main purpose of loading dose(D*) is to provide a steady-state concentration in plasma during multiple dosing. 6/5/2022 8
  • 9.
    Loading dose basedon Cmax ss  The max concentration of drug in the plasma at steady-state, Cmax ss is given by equation C0 is plasma concentration immediately after administration of a single dose. e-p is persistence factor where P=(Ke) (T) 6/5/2022 9
  • 10.
     If thedrug follows linear pharmacokinetics then C0 obtained after the administration of single i.v rapid bolus dose is directly proportional to size of dose D(maintenance dose).  The max concentration at steady-state is 6/5/2022 10
  • 11.
     Concentration ofdrug in plasma immediately after administration of the first dose is given by  Vd= apparent volume of distribution  therefore 6/5/2022 11
  • 12.
     The maxconc after the first dose is  Since Cmax 1 = Cmaxss, the conc *C0 of drug in plasma immediately after (D*) is given by *C0 = Cmaxss  Substuting *C0 and Cmaxss gives 6/5/2022 12
  • 13.
     The sizeof loading dose depends on the following factors- a) Maintenance dose ,D b) Elimination rate constant , Ke c) Dosing interval ,T. 6/5/2022 13
  • 14.
    Loading dose basedon Cmin ss  The minimum concentration of drug in plasma at steady-state is given by equation  If drug follows linear p’kinetics then C0 is directly proportional to size of D  The min concentration of drug in plasma at steady-state is 6/5/2022 14
  • 15.
     When asingle bolus dose of the drug is administered intravenously  Therefore 6/5/2022 15
  • 16.
     The minconc of drug in plasma after administration of first dose  For D* Cmin 1 = (*C0 ) (e-p ),which should be equal to Cmin ss  Combining eq 6/5/2022 16
  • 17.
     Common termscanceled 6/5/2022 17
  • 18.
    Factors affecting sizeof dose  If all doses and all T are kept constant, then the size of D depends on size of D*, T & Ke Effect of dosing interval:  If the size of D is kept constant & biological halflife of the drug dose not change during the course of therapy, the size of D* depends entirely upon the T of a given drug. 6/5/2022 18
  • 19.
    EXTRAVASCULAR ADMINISTRATION  For thedetermination of D* during e.v, administration, the simplest case is a drug which, when administered, confers upon the body the characteristics of one-compartment model, & does not exhibit lag-time.  The size of D* needed to attain steady-sate conc of drug in plasma depends on: 6/5/2022 19
  • 20.
    a. Maximum concentrationof drug in plasma at steady state. OR b. Minimum concentration of drug in plasma at steady state. LOADING DOSE BASED ON Cmaxss  The maximum concn of drug in plasma at steady-state is given by 6/5/2022 20
  • 21.
     Where Bis the back extrapolated y- intercept of the elimination phase after administration of a single dose.  R=(Ke) (tmax) 6/5/2022 21
  • 22.
    Loading dose basedon Cmin ss  The minimum conc of drug in plasma following e.v adminstration of n dose  If the drug follows linear pharmacokinetics then B  F=fraction of dose absorbed  G= (Ka)( T) 6/5/2022 22
  • 23.
     By settingn=1 in above eq in Cmin1  Canceling common terms  When n becomes large, the two exponential terms e-np e-nG approach 0 6/5/2022 23
  • 24.
     Since they-intercept,Cmin1 is directly proportional to D  If D is administered at the first dose 6/5/2022 24
  • 25.
     When Cmin1=Cminss Substituting the values  Bringing RHS of eq to common denominator  Upon simplification 6/5/2022 25
  • 26.
     Dividing bothside by (e-p – e-G)  Cancelling common term 6/5/2022 26
  • 27.
    Maintenance Dose  Afterthe loading dose is given the another dose is given to maintain the steady- state drug conc. / plateau. Such dose is known as maintenance dose.  i.e. maintain the response of drug by replacing drug lost during dosing interval 6/5/2022 27
  • 28.
     Maintenance dose= loading dose . ( 1- e k‫ז‬)  Loading dose =  The ratio of loading dose to maintenance dose (X0l/X0) is called as dose ratio  When ‫ז‬ = t1/2 the dose ratio =2.0  When ‫ז‬ > t1/2 the dose ratio < 2.0  when ‫ז‬ < t1/2 the dose ratio >2.0 6/5/2022 28
  • 29.
  • 30.
    Maintenance of drugwithin the therapeutic range The ease or difficulty in maintaining drug concentration within the therapeutic window depends on-  The Therapeutic index of drug  The Half- life of drug  Convenience of dosing 6/5/2022 30
  • 31.
    REFERENCE  Madan PL;Biopharmaceuticsand pharmacokinetics. Jaypee.2010(1);365-80.  Brahmankar DM, Sunil Jaiswal B; Biopharmaceutics and Pharmacokinetics- A Treatise. Vallabh publication. 2014(3); 374-76.  C V S Subrahmanyam. Textbook of Biopharmaceutics & pharmacokinetics.1st edition 2010;456-61. 6/5/2022 31
  • 32.